FMS
FMS's valuation appears fair, fundamentals are above averages, but weaker than expected earnings are holding it back, though analyst coverage is limited and estimates vary widely.
FMS vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 11x | 26x | 55% lower-55% |
| PE percentile | 2.6 | 50 | 95% lower-95% |
| EPS | $1.95 | $1.06 | 84% higher+84% |
| FCF | $2.1B | $2B | 4% higher+4% |
| Loading historical comparisons… | |||
FMS’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.
FMS Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Strongly deteriorating |
| Forward earnings | Strong decline |
| Forward revenue | Stable |
| Forward profitability | -- |
| Analyst coverage | Limited |
| Estimate dispersion | Wide |
FMS’s outlook is weakening, with weaker expected earnings weighing on the picture.
FMS PE Valuation
This table applies FMS's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
FMS Earnings Per Share
This chart tracks FMS's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
FMS Quarterly Revenue
This chart tracks FMS's quarterly revenue over time and shows how sales are changing from year to year.
FMS Free Cash Flow
This chart tracks FMS's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
FMS Total Shares
This chart tracks changes in FMS's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
FMS Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
FMS PE vs Healthcare Sector
This chart compares FMS's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
FMS Weekly Price
This chart uses FMS's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
FMS Weekly Moving Averages
This chart compares FMS's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
FMS Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.
LLY
LLY's valuation is historically cheap, fundamentals are above averages and forward estimates point to improving growth and profitability.
LLY vs Historical averages
| Metric | Current | AverageAverage | Relative |
|---|---|---|---|
| PE | 37x | 57x | 35% lower-35% |
| PE percentile | 30 | 50 | 40% lower-40% |
| EPS | $29.80 | $9.50 | 214% higher+214% |
| FCF | $20.1B | $3.2B | 525% higher+525% |
| Loading historical comparisons… | |||
LLY’s earnings and cash flow are above their historical averages, while its earnings multiple is lower.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Forward valuation | Strongly improving |
| Forward earnings | Strong growth |
| Forward revenue | Growth |
| Forward profitability | Expanding |
| Analyst coverage | Moderate |
| Estimate dispersion | Moderate |
LLY’s outlook is generally improving, with growth expectations supporting the valuation case.
LLY PE Valuation
This table applies LLY's historical price-to-earnings (PE) landmarks to current earnings. The implied prices are valuation scenarios, not price forecasts or targets.
LLY Earnings Per Share
This chart tracks LLY's trailing twelve-month diluted earnings per share, calculated from four consecutive reported quarters to reduce seasonal noise.
LLY Quarterly Revenue
This chart tracks LLY's quarterly revenue over time and shows how sales are changing from year to year.
LLY Free Cash Flow
This chart tracks LLY's free cash flow over time, showing whether the business is consistently generating cash after operating costs and capital spending.
LLY Total Shares
This chart tracks changes in LLY's diluted share count. A rising count can dilute existing owners, while a falling count often reflects share repurchases.
LLY Net Leverage
Quarterly Net Leverage uses the last 12 months of EBITDA. A falling multiple generally indicates less debt relative to earnings capacity. Negative values mean net cash; missing data or nonpositive LTM EBITDA are N/A. The table shows each period’s Net Leverage and status.
LLY PE vs Healthcare Sector
This chart compares LLY's price-to-earnings (PE) ratio with the Healthcare sector average. A discount or premium can reflect differences in expected growth, profitability, or risk.
LLY Weekly Price
This chart uses LLY's weekly closing prices to show the longer-term trend. The lower panes show weekly RSI and Stochastic momentum.
LLY Weekly Moving Averages
This chart compares LLY's 8, 20, 50, 100, and 200-week moving averages from 2020 onward. Shorter averages react faster to price changes, while longer averages show the broader trend.
LLY Yearly ROI
Each line starts at 0% using the year’s first dependable weekly close and tracks the return through December, or through the latest available week for the current year.